Importantly, TGFβ is a well-established mediator of myeloid immune suppression and tumor-promoting inflammation and has been shown to cooperate with STAT3 signaling to reinforce pro-tumorigenic immune phenotypes [20,21,22]. This evidence concerns the gene TGFB1 and neoplasm.